Showing 121 - 140 results of 99,043 for search '(( 5 step decrease ) OR ( 5 ((((nn decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.42s Refine Results
  1. 121
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126
  7. 127
  8. 128
  9. 129

    Metabolites which (A) persistently increased and (B) persistently decreased with smoking. by Charmion I. Cruickshank-Quinn (595143)

    Published 2014
    “…PIP = phosphatidylinositol phosphate, PS = phosphatidylserine, TG = triglyceride, DG = diglyceride, PE = phosphatidylethanolamine. Fold change ≥1.5; <i>p</i>-value≤0.05, x-axis = Log2 normalized abundance scale; Error bars represent 95% confidence; Significance values *≤0.05, **≤0.01, ***≤0.001.…”
  10. 130
  11. 131
  12. 132
  13. 133

    Effects of ATP and primer-template binding on RecA-UmuC cross-linking efficiency in pol V Mut. by Angela J. Gruber (712958)

    Published 2015
    “…<p>Western blot using an antibody to UmuC demonstrating increased UmuC-RecA cross-linking with increasing ATPγS concentration and decreasing UmuC-RecA cross-linking with increasing primer-template concentration in the presence of 500 μM ATPγS. pol V Mut was generated using RecA N113Bpa as described in Methods, with ATPγS and primer-template hairpin DNA added where indicated. …”
  14. 134
  15. 135

    (R+S) and (R)-albuterol decrease NF-κB activity by Marcela A Ferrada (41716)

    Published 2011
    “…After transfection, (R)-albuterol (R), (S)-albuterol (S), or racemic albuterol (R+ S) were added to cells pre-activated with (ConA, 5 μg/ml) and (PMA, 100 ng/ml) (CP) and then treated with (R)-, (S)-, or (R+S)-albuterol (Fig. 6). …”
  16. 136
  17. 137
  18. 138
  19. 139
  20. 140

    (R)-albuterol decreases cytokine levels in activated murine splenocytes by Marcela A Ferrada (41716)

    Published 2011
    “…</p><p></p> (R)-albuterol (R), (S)-albuterol (S) or racemic albuterol (R + S) at a dose (10M) were added to murine splenocytes pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP), (Fig 3 A, B). …”